We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ADENOSINE JUNO (Juno Pharmaceuticals Pty Ltd)
Product name
ADENOSINE JUNO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
159 working days (255)
Active ingredients
Adenosine
Registration type
New generic medicine
Indication
ADENOSINE JUNO (solution for injection) is a coronary vasodilator for use in conjunction with radionuclide myocardial perfusion imaging, in patients unable to exercise adequately.